TONGCHENGTRAVEL

Tongcheng Travel closed essentially flat today at HKD13.17, trading within a range of HKD12.89–13.24 intraday, amid market divergence over the company's growth sustainability and profit-taking pressures. Q1 2026 results displayed robust performance with operating revenue of HKD56.75 billion (+21.06% YoY) and net profit of HKD884 million (+23.33% YoY), achieving a healthy margin of 15.57%, yet Q4 2025's sharp deterioration to just 1.75% net margin has triggered sellside concern over earnings momentum. Recent analyst consensus shifts underscore caution: UBS cut price target to HKD20, CLSA to HKD13, Citi to HKD22, and CICC to HKD15, all reflecting unease around earnings visibility and value realization from the Tongcheng-eLong joint offer for Dida Inc. The stock trades at a depressed valuation (PE 11x) and sits 48.19% below its 52-week high and down 42.94% year-to-date, but the stark Q1–Q4 earnings divergence and uncertainty surrounding the acquisition deal continue to weigh on upside potential.

Tongcheng Travel rose 2.17% to HKD 13.18 today, supported by recent analyst target price cuts. UBS lowered its target to HKD 20, CLSA to HKD 13, and Citi to HKD 22, with the current price trading below most estimates and offering value. Fundamentally, Q1 2026 showed strong recovery: EPS climbed 20.46% to HKD 0.3741, revenue reached HKD 53.75 billion up 21.06% year-on-year, operating profit surged 31.02%, and net margin expanded to 15.57%—a marked reversal from Q4's dismal 1.75% margin and 74.81% profit decline. Valuation remains attractive at PE 11.04x. Year-to-date the stock is down 42.89% from opening levels, with a 48.15% pullback from 52-week highs. However, the latest development—Tongcheng and eLong delaying submission of composite documents for the conditional Dida takeover—introduces uncertainty into acquisition timing.

Tongcheng Travel closed at HK$12.9 with afternoon gains offset by delayed merger headlines, illustrating tension between deal uncertainty and solid earnings momentum. The company and eLong postponed filing conditional documents for the Dida acquisition, injecting near-term doubt; meanwhile, Q1 results offered fundamental support with revenue reaching HK$5.68B (+21.06% YoY), net profit at HK$884M (+23.33%), EPS at HK$0.3741 (+20.46%), and ROE at 13.71%. Analyst sentiment diverges widely: UBS cut target to HK$20, CLSA set a cautious HK$13, Citi maintained HK$22 with Buy intact, while Macquarie held its Buy rating. The stock has tumbled 44.11% year-to-date, sliding 49.25% from the 52-week high of HK$25.42 and trading just 10.54% above the 52-week low of HK$11.67, at a subdued PE of 10.81 and PB of 1.17. Lingering merger ambiguity may continue constraining recovery.

Tongcheng Travel recovered 0.54% to HKD 13.16 today, bouncing from an intraday low of HKD 12.90 recorded in the morning trading session and closing higher in afternoon transactions. The modest rebound comes despite a wave of recent analyst downgrades, as UBS, CLSA, and Citi have each cut their price targets to HKD 20, 13, and 22 respectively, while Macquarie and CICC maintain Buy ratings. Fundamentally, Q1 2026 results demonstrated solid performance with revenues climbing 21% year-over-year to HKD 5.68 billion, net profit surging 23% to HKD 884 million, and net profit margin reaching 15.57%, reflecting growth across accommodation bookings and transportation services. The company's pending acquisition offer for ride-hailing platform Dida Inc. continues to progress, with relevant documentation recently disclosed. From a pricing perspective, the stock is down 43% year-to-date and 48% from its 52-week peak of HKD 25.42 set in January, though it has recovered 13% from late-June lows. Current valuation metrics appear reasonable with PE of 11.02 and PB of 1.19, though the successful realization of Dida integration synergies—a critical value component—remains subject to significant market debate.

Tongcheng Travel rose about 2.5% today, mainly supported by Q1 earnings beat and positive analyst ratings. Q1 operating revenue reached 5.68B HKD with 21% YoY growth, net profit hit 884M HKD with 23% YoY growth, and EPS grew 20.46% YoY; notably net margin rebounded sharply from 1.75% in Q4 to 15.57%, signaling clear seasonal recovery. Macquarie and CICC maintained or reaffirmed buy ratings. The stock has declined 43% YTD to 13.09 HKD, down 48.5% from 52-week high of 25.42 HKD, but up 12.2% from 52-week low of 11.67 HKD. Valuation remains reasonable with PE 10.96 and PB 1.19; price is trading above 20-day MA. However, recent analyst target prices show divergence: UBS cut TP to 20 HKD, CLSA cut to 13 HKD, and Citi maintained 22 HKD, reflecting mixed expectations for near-term growth momentum.